ALK-driven tumors and targeted therapy: focus on crizotinib
Carlos Murga-Zamalloa, Megan S Lim Department of Pathology, University of Michigan, Ann Arbor, MI, USA Abstract: Receptor tyrosine kinases have emerged as promising therapeutic targets for a diverse set of tumors. Overactivation of the tyrosine kinase anaplastic lymphoma kinase (ALK) has been report...
Na minha lista:
| Principais autores: | , |
|---|---|
| Formato: | Livro |
| Publicado em: |
Dove Medical Press,
2014-03-01T00:00:00Z.
|
| Assuntos: | |
| Acesso em linha: | Connect to this object online. |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|
Internet
Connect to this object online.3rd Floor Main Library
| Número de Chamada: |
A1234.567 |
|---|---|
| Cópia 1 | Disponível |